T1	Treatment 51 67	nelfinavir-based
T2	Treatment 243 258	antiretrovirals
T3	Treatment 496 582	NRTI, protease inhibitors +/- a nonnucleoside reverse transcription inhibitor (NNRTI).
T4	Treatment 787 913	nelfinavir (NFV) 30 mg/kg twice daily (bid), ritonavir (RTV) 400 mg/m bid and buffered didanosine (ddI) 240 mg/m daily (arm A)
T5	Treatment 917 1007	NFV 50-55 mg/kg bid, nevirapine (NVP) 120 mg/m bid and stavudine (d4T) 1 mg/kg bid (arm B)
T6	Treatment 1560 1575	NFV + RTV + ddI
T7	Treatment 1583 1598	NFV + NVP + d4T
T8	Treatment 2046 2054	NVP, RTV
T9	Treatment 2059 2062	d4T
